Mitotag, Biocant Park, Parque Tecnológico de Cantanhede, Núcleo 04, Lote 4, 3060-197 Cantanhede, Portugal.
CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.
Biomolecules. 2021 Oct 29;11(11):1605. doi: 10.3390/biom11111605.
Mitochondriotropic antioxidants (MC, MC, MC and MC) based on dietary antioxidants and analogs (caffeic, hydrocaffeic, trihydroxyphenylpropanoic and trihydroxycinnamic acids) were developed. In this study, we evaluate and compare the cytotoxicity profile of novel mitochondria-targeted molecules (generally known as MitoCINs) on human HepG2 and differentiated SH-SY5Y cells with the quinone-based mitochondria-targeted antioxidants MitoQ and SkQ and with two non-targeted antioxidants, resveratrol and coenzyme Q (CoQ). We further evaluate their effects on mitochondrial membrane potential, cellular oxygen consumption and extracellular acidification rates. Overall, MitoCINs derivatives reduced cell viability at concentrations about six times higher than those observed with MitoQ and SkQ1. A toxicity ranking for both cell lines was produced: MC < MC < MC < MC. These results suggest that C-6 carbon linker and the presence of a pyrogallol group result in lower cytotoxicity. MC and MC affected the mitochondrial function more significantly relative to MitoQ, SkQ1, resveratrol and CoQ, while MC and MC displayed around 100-1000 times less cytotoxicity than SkQ1 and MitoQ. Based on the mitochondrial and cytotoxicity cellular data, MC and MC are proposed as leads that can be optimized to develop safe drug candidates with therapeutic application in mitochondrial oxidative stress-related diseases.
基于膳食抗氧化剂和类似物(咖啡酸、羟基咖啡酸、三羟苯基丙酸和三羟基肉桂酸)开发了靶向线粒体的抗氧化剂(MC、MC、MC 和 MC)。在这项研究中,我们评估并比较了新型靶向线粒体分子(通常称为 MitoCINs)对人 HepG2 和分化的 SH-SY5Y 细胞的细胞毒性谱,与醌基靶向抗氧化剂 MitoQ 和 SkQ 以及两种非靶向抗氧化剂白藜芦醇和辅酶 Q(CoQ)。我们进一步评估了它们对线粒体膜电位、细胞耗氧量和细胞外酸化率的影响。总体而言,MitoCINs 衍生物在浓度约为 MitoQ 和 SkQ1 观察到的浓度高 6 倍的情况下降低细胞活力。对两种细胞系产生了毒性排序:MC <MC <MC <MC。这些结果表明,C-6 碳连接子和焦儿茶酚基团的存在导致更低的细胞毒性。MC 和 MC 对线粒体功能的影响比 MitoQ、SkQ1、白藜芦醇和 CoQ 更显著,而 MC 和 MC 的细胞毒性比 SkQ1 和 MitoQ 低约 100-1000 倍。基于线粒体和细胞毒性数据,MC 和 MC 被提议作为先导化合物,可以对其进行优化,以开发具有治疗线粒体氧化应激相关疾病应用的安全候选药物。